Wokingham

WOKINGHAM, England, October 4, 2011 - Safer, Faster and Smarter Medication Labelling Anywhere Syringes Are Prepared PRISYM ID Limited, a leading provider of labelling and identification solutions, announced today a sole distribution agreement for England, Wales and Scotland with Codonics to supply a safe labelling system - the Codonics Safe Label System SLS 500i - to healthcare organizations.

WOKINGHAM, England, July 18, 2011 - - Study Demonstrated no Significant Impact on Blood Levels When LIVAZO (pitavastatin) was Taken With HIV Protease Inhibitor Combination lopinavir/ritonavir in Healthy Volunteers Kowa Pharmaceuticals America, Inc.

WOKINGHAM, England, June 27, 2011 - Today, at the European Atherosclerosis Society (EAS) congress, Kowa Pharmaceutical Europe announced results from a post marketing surveillance study showing pitavastatin provides consistent long-term increases in high-density lipoprotein cholesterol (HDL-C) in a broad range of patients with hypercholesterolaemia.[1] The data from the Livalo Effectiveness and Safety (LIVES) Study Extension showed a relationship between on-treatment serum HDL-C levels and cardiovascular risk, and that pitavastatin consistently provided clinically relevant elevations in HDL-C that continued to increase over five years.

WOKINGHAM, England, May 3, 2011 - Kowa Pharmaceutical Europe welcomes the first European launch of its statin, pitavastatin in Spain, where it will be marketed and distributed as Livazo(R) by Recordati, and as Alipzadegrees by Recordati's partner distributor, Esteve.

WOKINGHAM, England, March 23, 2011 - Kowa Pharmaceutical Europe welcomes the first regional launch of its statin, Livazo (pitavastatin) in Lebanon, where it will be marketed by Beirut-based Algorithm, under an exclusive license.